Phenolic excipients of insulin formulations induce cell death, pro-inflammatory signaling and MCP-1 release

Skin reactions at the infusion site are a common side effect of continuous subcutaneous insulin infusion therapy. We hypothesized that local skin complications are caused by components of commercial insulin formulations that contain phenol or m-cresol as excipients. The toxic potential of insulin so...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Claudia, Kammerer, Daniel, Streit, Bettina, Licht, Alexander H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598374/
https://www.ncbi.nlm.nih.gov/pubmed/28962351
http://dx.doi.org/10.1016/j.toxrep.2014.11.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598374/
https://www.ncbi.nlm.nih.gov/pubmed/28962351
http://dx.doi.org/10.1016/j.toxrep.2014.11.019

Ejemplares similares